Among these breast cancer subtypes [luminal A, luminal B, ERBB2/HER2-positive, and triple-negative (TNBC) breast cancer], luminal A (ER+ and/or PR+, ERBB2-, low Ki-67) is the most common type, which accounts for approximately 40% of all breast cancer cases. This evidence concerns the gene ERBB2 and breast cancer.